Kolexia
Portales Fabienne Gastro-entérologie
Portales Fabienne
Gastro-entérologie
Icm Montpellier
Montpellier, France
113 Activités
158 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du pancréas Adénocarcinome Tumeurs colorectales Métastase tumorale Fatigue Tumeurs des voies biliaires Carcinomes Tumeurs gastro-intestinales Tumeurs du côlon

Collaborateurs

Voir plus
Ychou Marc
Ychou Marc
Icm Montpellier, Montpellier, France
Samalin Scalzi Emmanuelle
Samalin Scalzi Emmanuelle
Icm Montpellier, Montpellier, France
Assenat Eric
Assenat Eric
Icm Montpellier, Montpellier, France
Mazard Thibault
Mazard Thibault
Icm Montpellier, Montpellier, France

Industries

Voir plus
Servier
5 collaboration(s)
Dernière en 2023
Ipsen
3 collaboration(s)
Dernière en 2021
MSD
3 collaboration(s)
Dernière en 2022
Advanced Accelerator Applications
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 février 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   16 janvier 2024
GABRINOX2: Randomized Phase II Trial Evaluating the Efficacy of a Sequential Treatment Gemcitabine Plus Nab-paclitaxel (Gembrax) Followed by Folfirinox Versus Folfirinox Alone in Patients Treated in First Metastatic Line Pancreatic Cancer
Essai Clinique (Institut du Cancer de Montpellier)   25 septembre 2023
GABRINOX-ART: Phase II Study to Assess the Interest of a Sequential Treatment With Gemcitabine/Nab-paclitaxel (GEMBRAX) and Then FOLFIRINOX Followed by Stereotactic Magnetic Resonance-guided Adaptive Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Essai Clinique (Institut du Cancer de Montpellier)   25 septembre 2023
COLOFIGHT: Feasibility Study of a Hypnosis Intervention and a Cognitive Behavioral Therapy Intervention to Reduce Fatigue in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
Essai Clinique (Institut du Cancer de Montpellier)   15 juin 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study.
Cancers   20 décembre 2022
BCBPancréas: Establishment of a Monocentric and Prospective Clinico-biological Database in Patients With Pancreatic Adenocarcinoma
Essai Clinique (Institut du Cancer de Montpellier)   16 novembre 2022
Hypnosis and cognitive behavioral therapy with online sessions to reduce fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: Rational and study protocol for a feasibility study.
Frontiers in psychology   27 juillet 2022
REGOMUNE: Phase II study of regorafenib plus avelumab in solid tumors—Results of the gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) cohort.
2022 ASCO Annual Meeting I   02 juin 2022
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy: A multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
2022 ASCO Annual Meeting I   02 juin 2022